• HOME
  • SITE MAP
  • TÜRKÇE
  • COMPANY
    • ABOUT US
    • OUR VALUES
    • OUR QUALITY POLICY
      • QUALITY CERTIFICATIONS
    • NEWS AND PRESS RELEASES
  • PRODUCTS & SERVICES
    • ROBOTIC CHEMOTHERAPY DRUG COMPOUNDING SYSTEMS
      • WHY APOTECAchemo?
      • CLINICAL VALIDATIONS
      • PRODUCT PHOTO GALLERY
      • PRODUCT INTRODUCTION VIDEOS
      • PRODUCT BROCHURE
    • COMPOUNDING SYSTEM (Semi Automatic) DRUG COMPOUNDING SYSTEMS
    • CLOSED SYSTEM-MANUEL CHEMOTHERAPY DRUG PREPARATION
      • BD PHASEAL CLOSED SYSTEM DRUG TRANSFER DEVICE
    • DRUG ADMINISTRATION INFUSION SYSTEMS
      • LATERAL LINES
      • DRUG ADMINISTRATION IV SETS
      • INFUSION PUMPS
      • ADMINISTRATION TREES
    • CHEMOTHERAPY CLINICAL INFORMATION SYSTEMS SOFTWARE
    • WASTE SEALING SYSTEM
  • PROJECTS
    • REFERENCE PROJECTS
      • REFERENCE PROJECTS
      • INTERNATIONAL PRESS NEWS
      • INSTALLATION PROJECTS IN TURKEY
        • MANİSA CELAL BAYAR UNIVERSITY
        • MEDICALPARK PRIVATE HOSPITALS
  • DOCUMENTS
    • INTERNATIONAL STANDARTS
    • CLINICAL STUDIES
    • USEFUL LINKS
    • VIDEOS
  • CONTACT US
PRODUCTS & SERVICESCLOSED SYSTEM-MANUEL CHEMOTHERAPY DRUG PREPARATIONNEEDLELESS INJECTION CONNECTORS

 

NEEDLELESS BIDIRECTIVE INJECTION VALVES


  • Secure needlefree connectors for preventing healthcare professionals from accidental contaminations or needle injuries during cytotoxic drug preparations or adminiastrations. 
  • Suitable for use with all kind of male luer lock connection sites or syringes.
  • Easy to use with ergonomic design
  • Easy to disinfect

                                                             *LATEX AND PHTHALATE FREE.

 

 

 

NeutraClear

 

Related Literatures & Clinical Studies:

(1) CDC 2011 : «Potential explanations for outbreaks include (...) inadequate flushing of the device due to poor visualization of the fluid flow pathway in opaque devices».

(2) Jarvis W. 2010 : «The ability to visualize the internal surfaces of the needleless connector helps the clinician determine if flushing of the

needleless connector is complete (...) A transparent needleless connector is preferable to one that is opaque».

(3) CDC 2011.

(4) Sharps Safety 2009 ; Infection Control Today 2005 : «The split-septum products did not adress the problem of catheter occlusion».

(5) SHEA 2008 : «Do not routinely use positive-pressure needleless connectors».

(6) FDA 2010 : «The FDA is requiring (...) to conduct surveillance study on positive displacement needleless connectors to assess (...) a higher rate

 

NeutraClear

Cair~Drive

CAIR Drive Bidirective Needleless Connector

 

Copyright © 2012 | ONKOFAR | All Rights Reserved.
  Tasarım ve Yazılım Mavi Piksel
  • Linked-in
  • Facebook
  • Twitter
  • RSS